Clinical features of ATRX or DAXX mutated neuroblastoma

Journal of Pediatric Surgery

Volumn 49, Issue 12, 2014, Pages 1835-1838

  Kurihara, Sho ^a,b   Hiyama, Eiso ^a,b   Onitake, Yoshiyuki ^a,b   Yamaoka, Emi ^a   Hiyama, Keiko ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

ALT; ATRX; DAXX; Mutation; Neuroblastoma; Prognosis; Telomere

Indexed keywords

ANTINEOPLASTIC AGENT; TELOMERASE; ATRX PROTEIN, HUMAN; DAXX PROTEIN, HUMAN; DNA HELICASE; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ARTICLE; ATRX GENE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DAXX GENE; DISEASE ASSOCIATION; FEMALE; GENE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MALE; MISSENSE MUTATION; NEUROBLASTOMA; NONSENSE MUTATION; NUCLEAR LOCALIZATION SIGNAL; RESTRICTION FRAGMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; GENETICS; INFANT; MUTATION; NEWBORN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PROGNOSIS; TELOMERE HOMEOSTASIS; TUMOR RECURRENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA HELICASES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEUROBLASTOMA; NUCLEAR PROTEINS; PROGNOSIS; TELOMERE HOMEOSTASIS;

EID: 84916226903     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2014.09.029     Document Type: Article

References (32)

1. E. Hiyama, T. Iehara, and T. Sugimoto Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study Lancet 371 2008 1173 1180
2. E. Hiyama, and K. Hiyama Diagnostic and prognositic molecular markers in neuroblastoma 2009 Transworld Research Network Kerala 135 162
3. T.J. Pugh, O. Morozova, and E.F. Attiyeh The genetic landscape of high-risk neuroblastoma Nat Genet 45 2013 279 284
4. R.J. Deyell, and E.F. Attiyeh Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma Cancer Genet 204 2011 113 121
5. Y.P. Mosse, M. Laudenslager, and L. Longo Identification of ALK as a major familial neuroblastoma predisposition gene Nature 455 2008 930 935
6. D. Trochet, F. Bourdeaut, and I. Janoueix-Lerosey Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma Am J Hum Genet 74 2004 761 764
7. E. Hiyama, K. Hiyama, and T. Yokoyama Correlating telomerase activity levels with human neuroblastoma outcomes Nat Med 1 1995 249 255
8. E. Hiyama, K. Hiyama, and J.W. Shay Immunhistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues Neoplasia 3 2001 17 26
9. Y. Onitake, E. Hiyama, and N. Kamei Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres J Pediatr Surg 44 2009 2258 2266
10. N.K. Cheung, J. Zhang, and C. Lu Association of age at diagnosis and genetic mutations in patients with neuroblastoma JAMA 307 2012 1062 1071
11. G.M. Brodeur, J. Pritchard, and F. Berthold Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment [see comments] J Clin Oncol 11 1993 1466 1477
12. H. Shimada, I.M. Ambros, and L.P. Dehner The International Neuroblastoma Pathology Classification (the Shimada system) Cancer 86 1999 364 372
13. S. Sawaguchi, M. Kaneko, and J. Uchino Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Study Group of Japan Cancer 66 1990 1879 1887
14. E. Yuan, F. Haghighi, and S. White A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons Cancer Res 66 2006 3443 3451
15. J. Zhang, C.A. Benavente, and J. McEvoy A novel retinoblastoma therapy from genomic and epigenetic analyses Nature 481 2012 329 334
16. C.M. Heaphy, R.F. de Wilde, and Y. Jiao Altered telomeres in tumors with ATRX and DAXX mutations Science 333 2011 425
17. E. Hiyama, T. Yokoyama, and K. Hiyama Alteration of telomeric repeat length in adult and childhood solid neoplasias Int J Oncol 6 1995 13 16
18. M. Hashimoto, S. Kyo, and K. Masutomi Analysis of telomeric single-strand overhang length in human endometrial cancers FEBS Lett 579 2005 2959 2964
19. S.A. Stewart, I. Ben-Porath, and V.J. Carey Erosion of the telomeric single-strand overhang at replicative senescence Nat Genet 33 2003 492 496
20. N.W. Kim, M.A. Piatyszek, and K.R. Prowse Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
21. M.A. Piatyszek, N.W. Kim, and S.L. Weinrich Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP) Methods Cell Sci 17 1995 1 15
22. E. Hiyama, H. Yamaoka, and S. Kondo Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification Pediatr Surg Int 23 2007 1051 1058
23. E. Hiyama, K. Hiyama, and K. Ohtsu Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behavior? Eur J Cancer 33 1997 1932 1936
24. C.P. Reynolds, J.J. Zuo, and C.M. Hong Telomerase RNA expression in neuroblastoma correlates with high stage and clinical outcome Proc A Assoc Cancer Res 37 1996 199
25. E. Hiyama, K. Hiyama, and T. Yokoyama Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics Jpn J Cancer Res 83 1992 159 164
26. C.A. Lovejoy, W. Li, and S. Reisenweber Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway PLoS Genet 8 2012 e1002772
27. K. Bower, C.E. Napier, and S.L. Cole Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres PLoS One 7 2012 e50062
28. S. Sridhar, B. Al-Moallem, and H. Kamal New insights into the genetics of neuroblastoma Mol Diagn Ther 17 2013 63 69
29. G.M. Brodeur, R.C. Seeger, and M. Schwab Amplification of N-myc in untreated human neuroblastoma correlated with advanced stage Science 224 1984 1121 1124
30. L. Wylie, and A. Philpott Neuroblastoma progress on many fronts: the Neuroblastoma Research Symposium Pediatr Blood Cancer 58 2012 649 651
31. T. Ogura, E. Hiyama, and N. Kamei Clinical feature of anaplastic lymphoma kinase-mutated neuroblastoma J Pediatr Surg 47 2012 1789 1796
32. E. Hiyama, and K. Hiyama Molecular and biological heterogeneity in neuroblastoma Curr Genomics 6 2005 319 332